Rigel Pharmaceuticals, Inc. ( RIGL) - Key Metrics
RIGL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $3.88 | $14.90 | $1.22 | $1.22 |
| 2025Q3 | $3.85 | $1.55 | $1.33 | $1.33 |
| 2025Q2 | $5.69 | $3.33 | $1.71 | $1.71 |
| 2025Q1 | $2.99 | $0.64 | -$0.05 | -$0.05 |
RIGL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 0.72 |
| 2025Q3 | ? | 4.58 |
| 2025Q2 | ? | 1.40 |
| 2025Q1 | ? | 7.00 |
RIGL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.55% | ? |
| 2025Q4 | 2.85% | ? |
| 2025Q3 | 4.70% | ? |
| 2025Q2 | 9.12% | ? |
| 2025Q1 | -0.28% | ? |
RIGL
Price: $32.56
52 week price:
Earnings Per Share: 19.29 USD
P/E Ratio: 1.36
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.8 million
Ebitda: -17.7 millionMarket Capitalization: 559.7 million